> The inspection report showed that 29% of the quality-control checks performed on the company’s proprietary blood-testing devices in October 2014 produced results outside the range considered acceptable by Theranos.
> In February 2015, an Edison-run test to measure a hormone that affects testosterone levels failed 87% of quality-control checks, the report said.
It doesn't look like they are using Edison to run most of their tests, so we can excuse the experimental tests if they aren't being used for actual patients. Chalk that up to work-in-progress.
What is absolutely inexcusable is their treatment of patients, especially when they found out that results were incorrect.
> Inspectors also found that Theranos sometimes released patients’ results even when the Edison devices used to run those tests produced erratic results in quality-control checks.
and
> The inspection report said Theranos didn’t notify doctors treating patients potentially affected by the erroneous results until mid-November, or seven weeks after the inspectors first identified the problems.
Seven weeks to notify customers that you may have fucked up a medical test? We reach out to customers about potential software bugs within an hour.
This is an instance where I am glad to have government slowing down innovation. "Move fast, break things" doesn't work when people's lives are at stake.
[1]: http://www.wsj.com/articles/theranos-devices-often-failed-ac...